Larvol Delta - Duvelisib-Exposure-to-Enhance-Immune-Profiles-of-T-Cells-in-Patients-With-Recurrent-or-Refractory-Diffuse-Large-BCell-Lymphoma-DEEP-T-CELLS-Study

Kymriah (tisagenlecleucel-T) - Novartis

Copiktra (duvelisib) - Secura Bio, Yakult Honsha

ETP-47187 - CNIO

http://clinicaltrials.gov/ct2/show/NCT04890236

Jan 23, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next